Financial Performance - The net loss for the year ended December 31, 2025, was $48.3 million, or $0.49 per share, compared to a net loss of $27.5 million, or $1.16 per share in 2024, indicating a year-over-year increase in net loss of 75.5%[5] - Net loss for the year ended December 31, 2025, was $48,259,189, compared to a net loss of $27,519,886 in 2024, representing an increase of 75%[19] - Cash flows from operating activities resulted in a net cash used of $27,786,464 in 2025, up from $19,148,067 in 2024, indicating a 45% increase in cash outflow[19] - The accumulated deficit increased to $142.7 million as of December 31, 2025, from $94.4 million in 2024, reflecting a rise of 51%[15] Cash and Securities - As of December 31, 2025, cash, cash equivalents, and marketable securities totaled $178.8 million, up from $97.5 million as of December 31, 2024, representing an increase of approximately 83%[5] - Cash and cash equivalents at the end of 2025 were $139,220,208, significantly up from $56,490,579 at the end of 2024, marking a 147% increase[19] - Proceeds from the issuance of common stock, pre-funded warrants, and warrants amounted to $107,617,495 in 2025, compared to $103,477,668 in 2024, showing a 4% increase[19] - Net cash provided by financing activities was $108,462,963 in 2025, compared to $103,477,668 in 2024, reflecting a 5% increase[19] - Purchases of investments in marketable securities were $39,094,847 in 2025, down from $60,455,103 in 2024, indicating a 35% decrease[19] - Maturities of investments in marketable securities increased to $41,600,000 in 2025 from $23,450,902 in 2024, representing a 77% increase[19] Expenses - Research and development expenses rose to $29.8 million in 2025 from $17.2 million in 2024, reflecting a 73.5% increase, which includes a $7.4 million non-cash write-off related to the acquisition of CorHepta[6] - Selling, general and administrative expenses increased to $23.6 million in 2025 from $11.4 million in 2024, marking a 106.1% rise, which includes $1.0 million in severance expenses[7] - Stock-based compensation expense rose to $15,309,924 in 2025, compared to $8,140,617 in 2024, which is an increase of 88%[19] - The write-off of in-process research and development was $7,357,294 in 2025, with no such expense recorded in 2024[19] Clinical Development - The Company is advancing IKT-001 into a global pivotal Phase 3 study in Pulmonary Arterial Hypertension (PAH), named IMPROVE-PAH, with approximately 140 patients in Part A and 346 patients in Part B[4] - The IMPROVE-PAH study is expected to be conducted at up to approximately 180 sites worldwide, with regulatory submissions filed in over 20 countries[9] - The Company has received confirmation of acceptance under the FAST-EU initiative, which aims to accelerate the approval of multinational clinical trials, potentially reducing authorization timelines to a maximum of 10 weeks[9] Assets - The total assets as of December 31, 2025, were $181.2 million, compared to $98.6 million as of December 31, 2024, indicating a growth of approximately 83.7%[15]

Business Model and Revenue Generation - The company is highly dependent on the successful development, marketing, and sale of its respiratory support products, which are critical to its business model[66]. - The company anticipates revenue generation through strategic relationships and distribution agreements, particularly with Glo-Med Networks Inc.[70]. - The company has executed various distribution agreements in different geographic regions, but these are subject to regulatory approvals, which may delay revenue realization[80]. - Future revenue generation will depend on market acceptance, pricing, and reimbursement from third-party payors for the company's products, which are currently under development[136]. - The company has not generated significant revenue from product sales and may never achieve profitability, as its ability to generate revenue relies on successful completion of product development and obtaining necessary regulatory approvals[137]. Regulatory and Compliance Challenges - The company may face challenges in obtaining regulatory approvals for its products, which could adversely impact its revenue and market expansion efforts[75]. - The company must maintain compliance with extensive government regulations, and failure to do so could result in enforcement actions that adversely affect its business operations[149]. - The company is subject to ongoing regulatory requirements even after obtaining clearance, which could result in increased costs or lower sales if compliance is not maintained[163]. - Regulatory changes could impose additional requirements that may delay the ability to obtain new clearances or approvals[165]. - The company must ensure that third-party manufacturers comply with applicable regulations to avoid delays in product delivery and potential enforcement actions[169]. Financial Condition and Funding - The company has incurred accumulated losses of approximately $80 million as of December 31, 2025, raising substantial doubt about its ability to continue as a going concern[131]. - The company has not generated significant revenues from its activities and has incurred substantial operating losses since its inception[131]. - The management expects to continue generating substantial operating losses and will primarily fund operations through current financial resources, product sales, and additional capital raises[131]. - As of December 31, 2025, the company had approximately $3.1 million in cash and cash equivalents, with a working capital of approximately $1.6 million, indicating a need for substantial additional funding to sustain operations[141]. - The company expects its existing cash and cash equivalents will be sufficient to fund operating expenses and capital requirements for the next six months, but substantial additional capital will be required for the next twelve months[247]. Competition and Market Risks - The company faces intense competition from established players in the medical device industry, which have greater resources and market share[96][97]. - Competitors may offer significant discounts, forcing the company to lower prices or offer favorable terms, impacting revenue potential[100]. - The company operates in a market characterized by rapid technological change, which may render its current or future products obsolete if it fails to innovate[76]. Intellectual Property Risks - The company faces risks related to intellectual property, including the potential inability to secure effective patent rights, which could hinder competitive positioning[208]. - Changes in patent laws could increase uncertainties and costs associated with the prosecution and enforcement of patents, potentially affecting the company's business[220]. - The company may be involved in costly and time-consuming lawsuits to protect its intellectual property, which could distract management and divert resources[221]. - The company may not be able to protect its intellectual property rights globally due to high costs and varying legal protections in different jurisdictions[226]. Operational and Workforce Challenges - The company has a small workforce of 37 full-time employees, and its future growth depends on retaining key personnel, particularly its CEO[91]. - The company may face difficulties in recruiting additional employees and consultants, which could disrupt operations[92]. - Management may need to divert attention from day-to-day activities to manage growth, potentially leading to operational mistakes and increased expenses[93]. International Operations and Political Risks - International expansion poses various risks, including regulatory approvals and compliance with multiple laws[94]. - The company’s operations may be adversely affected by political, economic, and military instability in Israel, including ongoing conflicts with Hamas and Hezbollah[250]. - The company has had employees called up for military service due to the current conflict, which may disrupt operations[255]. - The company may face increased operational risks due to potential boycotts, divestment, and sanctions against Israeli companies[256]. Market Dynamics and Legislative Changes - The U.S. Supreme Court reversed a decision denying $12 billion in "risk corridor" funding, impacting potential revenue streams for the company[191]. - The Inflation Reduction Act of 2022 extends enhanced subsidies for health insurance coverage in PPACA marketplaces through plan year 2025, which may affect the company's market dynamics[199]. - Medicare payment reductions of 2% per fiscal year, effective since April 1, 2013, will remain in effect until 2031, potentially impacting revenue from government programs[197]. - Legislative developments in the EU may impose additional requirements that could increase operating costs and delay marketing approvals for product candidates[192]. Shareholder and Securities Issues - The company received notices from Nasdaq regarding non-compliance with minimum bid price requirements, risking delisting[113][114]. - A potential delisting from Nasdaq could adversely affect the liquidity and market price of the company's shares[115]. - The trading price of the company's Ordinary Shares and Warrants has been volatile since the IPO in July 2021, influenced by broader market conditions and industry factors[231]. - Future sales of Ordinary Shares may lead to a decline in the market price of the company's securities, particularly if substantial amounts are sold on Nasdaq[233]. Future Outlook and Strategic Plans - The company plans to seek additional capital through various means, including private and public equity offerings, which may dilute existing shareholders' interests[146]. - Future acquisitions or strategic partnerships may increase capital requirements, dilute shareholders, and incur additional risks[117]. - The company expects significant increases in research and development expenses due to planned expanded studies and ongoing product development, leading to continued operating losses for the foreseeable future[135].

Financial Performance - For the year ended December 31, 2025, the company generated revenues of $359,700, a decrease of 10.3% from $401,000 in 2024[373]. - The company reported a net loss of $14.2 million for 2025, compared to a net loss of $8.98 million in 2024, representing a 58.5% increase in losses[372]. - As of December 31, 2025, the company had a working capital deficit of $586,029, a significant decrease from a working capital surplus of $7,395,815 in 2024[383]. - The company anticipates continued net losses and negative cash flows from operations as it executes its development plans for 2026 and beyond[372]. Expenses - Research and development expenses increased by 51% to $10,094,671 in 2025, up from $6,706,913 in 2024, primarily due to costs associated with the Phase 2 clinical trial[375]. - General and administrative expenses rose by 13% to $5,888,317 in 2025, compared to $5,221,209 in 2024, driven by increased stock-based compensation and headcount costs[377]. Cash Flow - For the year ended December 31, 2025, net cash used in operating activities was $10,788,963, primarily due to funding a net loss of $14,241,975[393]. - Net cash provided by investing activities was $8,897,470 for the year ended December 31, 2025, mainly from the sale of marketable securities which provided $11,692,686[394]. - Net cash provided by financing activities was $2,854,791 for the year ended December 31, 2025, due to net proceeds from common stock issuance[395]. - The company reported a net cash increase of $963,298 for the year ended December 31, 2025, compared to a decrease of $336,487 in 2024[392]. - The company experienced a significant increase in cash from investing activities in 2025 compared to 2024, rising from $514,529 to $8,897,470[394]. - The company’s net cash provided by financing activities decreased from $7,379,330 in 2024 to $2,854,791 in 2025[395]. Funding and Capital - The company sold 965,424 shares under an At The Market Offering Agreement, raising approximately $2.0 million in gross proceeds during 2025[369]. - The company expects to require significant additional funding to complete clinical trials and implement other programs, raising concerns about its ability to continue as a going concern[386]. - In February 2026, the company sold 12,560,715 shares of common stock and received net proceeds of approximately $4.5 million from the offering[390]. Business Operations - The company is developing the BRTX-100 product for chronic lower back pain and the ThermoStem Program for metabolic disorders, with several patents issued for these initiatives[362][363]. - The company does not believe that inflation had a material impact on its business or operating results during the reported periods[396]. - The company has no off-balance sheet arrangements that materially affect its financial condition or results of operations[400]. - The company’s critical accounting estimates are based on historical experience and reasonable assumptions, which may affect reported amounts of assets and liabilities[397].

Financial Performance - SKYX reported record annual revenue of $92 million in 2025, up from $86 million in 2024, marking an 8% year-over-year growth[1]. - The company generated $25 million in revenue in Q4 2025, compared to $24 million in Q4 2024, representing a 4% increase[4]. - Gross profit for 2025 increased to $28 million, a 13% rise from $25 million in 2024, with gross profit margin improving to 30%[6]. - Revenue for the year ended December 31, 2025, was $92,009,949, an increase of 6.4% compared to $86,276,876 in 2024[19]. - Operating expenses for 2025 totaled $121,122,339, up from $118,389,115 in 2024, indicating a 2.0% increase[19]. - Net loss attributed to common stockholders for 2025 was $34,474,779, compared to a net loss of $35,980,811 in 2024, reflecting a 4.2% improvement[19]. - The company reported a net loss per share of $0.32 for 2025, an improvement from a loss of $0.36 per share in 2024[19]. - Net loss for 2025 was $33,415,604, a slight improvement from a net loss of $35,768,144 in 2024, indicating a reduction of approximately 6.6%[21]. - Adjusted EBITDA for 2025 was $(11,375,344), improving from $(13,052,099) in 2024, reflecting a positive change of about 12.9%[23]. Cash Management - Operating cash used in 2025 was $13 million, down 27% from $18 million in 2024, indicating improved cash management[1]. - Total cash used in operating activities decreased to $13,291,059 in 2025 from $18,260,370 in 2024, representing a reduction of approximately 27.3%[21]. - Cash and cash equivalents decreased to $8,052,621 in 2025 from $12,639,441 in 2024, a reduction of 36.5%[18]. - Cash and cash equivalents at the end of 2025 were $10,102,621, down from $15,500,495 at the end of 2024, a decrease of about 34.9%[21]. - Net cash provided by financing activities decreased to $9,826,058 in 2025 from $13,062,040 in 2024, a decline of about 24.5%[21]. Assets and Liabilities - Total current assets decreased to $15,400,916 in 2025 from $20,374,450 in 2024, a decline of 24.5%[18]. - Total liabilities increased slightly to $57,303,620 in 2025 from $56,833,619 in 2024, representing a 0.8% increase[18]. - Total stockholders' equity (deficit) was $(4,588,386) in 2025, compared to $4,053,428 in 2024, indicating a significant decline[20]. - Inventory increased to $4,250,168 in 2025 from $3,785,346 in 2024, a rise of 12.3%[18]. - The weighted average number of common shares outstanding increased to 108,757,074 in 2025 from 99,766,866 in 2024, a growth of 9.9%[19]. Expenses - Interest expense increased to $4,303,214 in 2025 from $4,055,905 in 2024, marking an increase of approximately 6.1%[23]. - The company reported a depreciation and amortization expense of $4,320,338 in 2025, up from $4,066,957 in 2024, reflecting an increase of about 6.2%[23]. - Share-based payments remained relatively stable at $13,560,580 in 2025 compared to $13,474,433 in 2024, showing a marginal increase of 0.6%[23]. - The company did not incur any impairment of intangible assets in 2025, compared to an impairment of $1,118,750 in 2024[23]. - Proceeds from the issuance of common stock increased to $5,584,390 in 2025 from $4,426,222 in 2024, an increase of approximately 26.1%[21]. Future Outlook - The company expects to deploy over 100,000 products into homes/units by the end of 2026 through retail and professional segments[2]. - SKYX plans to launch a new AI-driven software for its e-commerce platform, which is anticipated to increase conversion rates and sales by up to 30%[3]. - The company is collaborating with NVIDIA to expand its smart home projects, aiming for significant growth in 2026[2]. - SKYX expects to supply over 1 million units of its advanced smart home technologies for key projects in the U.S. and globally[4]. - The company is progressing towards mandatory safety standardization for its ceiling outlet technology, which is expected to enhance market adoption and safety[7].

Financial Performance - Xos achieved positive operating cash flow and free cash flow of $2.4 million in Q4 2025, marking three consecutive quarters of cash-positive operations [2]. - Full-year operating expenses reduced by $14.0 million, or 28.2%, declining to $35.8 million from $49.8 million in 2024 [6]. - Operating loss narrowed by 27.9%, with a reported full-year operating loss of $33.1 million compared to $45.9 million in 2024 [6]. - EBITDA loss improved to $21.0 million from $42.2 million in 2024, reflecting a $21.2 million improvement [6]. - Revenues for Q4 2025 were $5,220,000, a decrease of 54.4% compared to $11,474,000 in Q4 2024 [25]. - Net loss for Q4 2025 was $9,752,000, compared to a net loss of $18,981,000 in Q4 2024, showing an improvement of 48.6% [25]. - Adjusted EBITDA for Q4 2025 was $(6,972,000), an improvement from $(11,957,000) in Q4 2024 [26]. - Free cash flow for Q4 2025 was $2,399,000, compared to $3,299,000 in Q4 2024, indicating a decrease of 27.2% [27]. - Gross profit for the twelve months ended December 31, 2025, was $2,724,000, down from $3,965,000 in 2024, a decline of 31.3% [25]. - Non-GAAP gross profit for Q4 2025 was $274,000, down from $2,667,000 in Q4 2024, a decline of 89.7% [29]. Production and Sales - Xos delivered 328 units in 2025, a 10% increase from 297 units in 2024, with revenue of $46.0 million compared to $56.0 million in 2024 [6]. - First production powertrains delivered for Blue Bird school buses, expanding into the school bus market [6]. - Xos plans to deliver between 350 to 500 units in 2026, with revenue forecasted between $40.0 million to $50.0 million [12]. Assets and Liabilities - Total current assets decreased to $49,877,000 in 2025 from $82,301,000 in 2024, representing a decline of 39.5% [23]. - Total liabilities decreased to $37,076,000 in 2025 from $64,723,000 in 2024, a reduction of 42.8% [23]. - Inventory reserves for Q4 2025 were $1,815,000, compared to $3,752,000 in Q4 2024, a decrease of 51.6% [28]. - The company reported a loss from operations of $(9,739,000) for Q4 2025, an improvement from $(14,572,000) in Q4 2024 [28]. Cash Position - Cash position strengthened to $14.0 million, up 28% from $11.0 million at year-end 2024 [6]. - Non-GAAP operating loss for 2026 is projected to be between $11.9 million to $13.3 million [12].

Financial Performance - INNOVATE Corp. reported consolidated revenue of $382.7 million for Q4 2025, a 61.7% increase from $236.6 million in Q4 2024[2] - The company's net loss attributable to common stockholders decreased to $7.8 million in Q4 2025, compared to a loss of $16.9 million in Q4 2024, marking a 53.8% improvement[12] - Total Adjusted EBITDA for Q4 2025 was $24.5 million, a 63.3% increase from $15.0 million in Q4 2024, driven primarily by the Infrastructure segment[12] - For Q4 2025, revenue was $382.7 million, a 61.5% increase from $236.6 million in Q4 2024; full-year revenue reached $1,246.0 million, up 12.6% from $1,107.1 million in 2024[33] - Gross profit for Q4 2025 was $58.9 million, compared to $46.4 million in Q4 2024, while full-year gross profit was $199.7 million, down from $208.8 million in 2024[33] - The net loss attributable to INNOVATE Corp. for Q4 2025 was $7.4 million, an improvement from a net loss of $16.6 million in Q4 2024; for the full year, the net loss was $60.6 million compared to $34.6 million in 2024[33] - Adjusted EBITDA for the three months ended December 31, 2025, was $24.5 million, compared to $15.0 million for the same period in 2024, reflecting a growth of 63.3%[37] - INNOVATE Corp. reported a net income of $29.5 million for the year ended December 31, 2025, compared to a net loss of $60.6 million in the same period of 2024[39] - Adjusted EBITDA for 2025 was $67.2 million, a decrease from $71.3 million in 2024, reflecting a decline of approximately 5.8%[39] Revenue Segments - The Infrastructure segment generated $373.9 million in revenue for Q4 2025, up 65.7% from $225.7 million in the prior year quarter, contributing significantly to overall growth[8] - The Spectrum segment reported a revenue decline to $5.7 million in Q4 2025 from $6.8 million in the prior year quarter, impacted by a softened advertising market[8] Cash and Assets - As of December 31, 2025, INNOVATE had cash and cash equivalents of $112.1 million, up from $48.8 million as of December 31, 2024[17] - Total current assets rose to $451.5 million in 2025, up from $390.9 million in 2024, which is an increase of 15.5%[35] - Total assets increased to $950.1 million in 2025, up from $891.1 million in 2024, representing a growth of 6.2%[35] - Current liabilities surged to $1,034.1 million in 2025, compared to $483.0 million in 2024, indicating a significant increase of 114.4%[35] - Total liabilities reached $1,165.4 million in 2025, up from $1,034.8 million in 2024, which is an increase of 12.6%[35] Operational Insights - INNOVATE's operating expenses for Q4 2025 were $45.0 million, slightly up from $44.8 million in Q4 2024, with selling, general and administrative expenses at $40.6 million[33] - The company reported a loss from operations before income taxes of $9.3 million in Q4 2025, an improvement from a loss of $14.9 million in Q4 2024[33] - DBM Global's gross margin was 14.7% in Q4 2025, a decrease of approximately 350 basis points year-over-year, indicating challenges in maintaining profitability[8] Future Outlook - INNOVATE is positioned for growth in 2026, supported by favorable contracts and ongoing trials with a major mobile wireless carrier[3] - The company plans to continue expanding its market presence and capitalize on potential growth opportunities in its strategic segments[26] - Forward-looking statements indicate expectations for future growth and performance in new projects and technologies, with a focus on advertising revenue growth and commercial opportunities in datacasting[26] - INNOVATE Corp. plans to focus on market expansion and new product development to drive future growth[39] - The company is actively pursuing acquisition opportunities to enhance its portfolio and market presence[39] Product Development - MediBeacon received FDA approval for the next generation MediBeacon TGFR System, enhancing the company's product offerings in Life Sciences[8] - R2 secured a minimum purchase agreement for 600 systems over three years in China, reflecting growing international demand[8] Interest and Expenses - Interest expense for the three months ended December 31, 2025, totaled $24.0 million, compared to $19.6 million in the same period of 2024, representing an increase of 22.4%[37] - The company incurred interest expenses totaling $89.0 million in 2025, up from $74.5 million in 2024, indicating a year-over-year increase of 19.8%[39] - Depreciation and amortization expenses were $17.5 million in 2025, slightly lower than $17.6 million in 2024[39] Losses and Deficits - The accumulated deficit increased to $(582.5) million in 2025 from $(521.9) million in 2024, indicating a deterioration of 11.6%[35] - The company reported a net loss in the Life Sciences segment of $3.5 million for Q4 2025, an improvement from a loss of $5.4 million in Q4 2024[37] - The company’s life sciences segment reported a net loss of $23.5 million in 2025, compared to a loss of $20.0 million in 2024, indicating a worsening performance[39] - The company reported a non-controlling interest loss of $3.4 million in 2025, compared to a loss of $5.1 million in 2024, showing a reduction of approximately 33.3%[39] - Realignment and exit costs amounted to $5.1 million in 2025, consistent with the $5.2 million reported in 2024[39]

Financial Performance - As of January 31, 2026, the project backlog for the Power segment was over $2.7 billion, up from approximately $1.3 billion as of January 31, 2025, indicating a significant increase in expected revenue from defined projects[24] - The Industrial segment's revenues were $167.6 million for Fiscal 2026, representing approximately 17.7% of consolidated revenues, consistent with the previous fiscal year[41] - Teledata segment revenues increased to $20.6 million in Fiscal 2026, accounting for approximately 2.2% of consolidated revenues, compared to $13.5 million in Fiscal 2025[49] - The Power segment's significant customer relationships accounted for approximately 23%, 16%, and 11% of consolidated revenues for Fiscal 2026, showing a shift from 28%, 13%, and 10% in Fiscal 2025[35] Financial Position - The company has a base lending commitment amount of $35.0 million under the Credit Agreement, with an additional accordion feature allowing for an extra commitment of $30.0 million[52] - As of January 31, 2026, the company had no borrowings outstanding under the Credit Agreement, with only a letter of credit issued for $0.3 million[53] - As of January 31, 2026, the company holds $150.0 million in certificates of deposit, $149.6 million in money market funds, and $402.5 million in U.S. Treasury notes, with a weighted average annual interest rate of 3.7%[271] - The company has a credit facility with a variable interest rate of SOFR plus 1.85%, with no outstanding borrowings as of January 31, 2026[272] - The company maintains material amounts of cash and short-term investments, with a commitment from the bank to issue standby letters of credit up to $60.0 million[58] - The weighted average number of days remaining until maturity for the company's certificates of deposit and U.S. Treasury notes was 963 days as of January 31, 2026[271] Risk Management - The company actively manages supply chain risks, which may cause delays in construction timelines and impact project costs due to material price fluctuations and tariffs[31] - Recent changes in U.S. trade policy have increased cost and supply chain uncertainty for construction materials, potentially affecting project costs and schedules[276] - The company is exposed to fluctuations in commodity prices, including steel, copper, concrete, and fuel, which may adversely affect results of operations[277] Workforce and Operations - The company employs 1,409 personnel as of January 31, 2026, with a focus on maintaining a stable and experienced workforce to support project execution[51] - The Industrial segment has emphasized the pursuit of larger field service construction projects and long-term fabrication projects in recent years[41] Safety and Governance - The reportable incident rates using OSHA methodology for the years 2021 to 2025 were 0.45, 0.56, 0.43, 0.60, and 0.48, respectively, indicating a commitment to workplace safety[55] - The responsible business committee of the board of directors oversees the company's strategy relating to environmental, health and safety, and corporate governance matters[59] Insurance and Financial Impact - The company has purchased specialty insurance related to the recovery of research and development tax credits claimed in prior fiscal years[57] - A hypothetical change of 100 basis points in interest rates would change annual investment earnings by $7.0 million[271] Competitive Landscape - The competitive landscape for the Power segment has seen a decline in capable competitors for domestic gas-fired power plant EPC work, potentially attracting new entrants due to growing demand[34]

Financial Performance - The fiscal year ended on December 31, 2025, with financial statements prepared in accordance with GAAP, presented in U.S. dollars[26] - Revenue for the years ended December 31, 2023, 2024, and 2025 was $569.9 million, $752.8 million, and $962.2 million, representing annual growth rates of 39.3%, 32.1%, and 27.8% respectively[50] - The company incurred net losses of $133.8 million in 2023 and $75.5 million in 2024, but achieved a net profit of $68.3 million in 2025[90] - The platforms generated a total Gross Merchandise Volume (GMV) of $6,569 million in 2025, representing a 35.2% increase compared to 2024[91] - The company anticipates increasing operating expenses in the coming years due to hiring, geographic expansion, and enhancements to its platforms[90] Key Metrics - Gross Merchandise Value (GMV) is defined as the total amount collected from shoppers and merchants, including products, duties, taxes, and shipping[28] - Adjusted EBITDA is defined as net profit adjusted for various expenses, with the Adjusted EBITDA margin calculated as Adjusted EBITDA divided by revenues[28] - Non-GAAP Gross Profit is defined as gross profit adjusted for amortization of acquired intangibles, with Non-GAAP gross margin calculated as Non-GAAP gross profit divided by revenues[28] - The Net Dollar Retention Rate is calculated by dividing the GMV in a given period by the GMV in the comparable period from the previous year[28] - The company emphasizes the importance of non-GAAP financial measures for evaluating performance and making operational decisions[29] Market and Growth Outlook - The e-commerce market is expected to experience growth, but estimates and forecasts may prove to be inaccurate due to uncertainties[32] - Future revenue growth is expected to be partially driven by increases in existing merchants' GMV, but there is no guarantee that historical acquisition rates can be sustained[55] - The company aims to sign contracts with merchants for a minimum term of 12 months, but merchants can terminate agreements for convenience, which may adversely affect revenue[52] - The ability to retain existing merchants and attract new ones is critical for future growth[40] - The company is focused on expanding its marketing and sales capabilities to enhance its market presence[41] Risks and Challenges - The company faces risks including rapid growth, market acceptance of platforms, and reliance on third-party services[40] - Changes in trade regulations or tariffs could adversely affect transaction volumes and operational strategies, impacting overall financial results[69] - The company faces competition in the e-commerce market, which could lead to decreased GMV processed through its platforms and reduced revenue[80] - The company faces risks associated with acquisitions, including integration challenges and potential unforeseen liabilities that could affect financial performance[57] - The company may need to change its pricing model to remain competitive, which could adversely affect its financial condition[82] Operational and Compliance Issues - The company must navigate varying international regulations and compliance requirements, which could increase operational complexity and costs[110] - The company operates as a merchant of record (MoR), which subjects it to product liability and regulatory compliance risks, including potential fines of up to 4% of annual EU turnover for non-compliance with regulations like the EU's General Product Safety Regulation (GPSR) and the EU Deforestation Regulation (EUDR) scheduled for December 30, 2026[114] - The company is subject to economic sanctions and export control laws, which require ongoing compliance efforts and could result in penalties for violations[124] - The company is subject to stringent and evolving laws regarding privacy, data protection, and data security, which could lead to increased costs and operational changes[149] - The company faces challenges in enforcing its intellectual property rights, which may lead to unauthorized use and competition from third parties[168] Technology and Cybersecurity - The implementation of artificial intelligence and machine learning technologies is critical, but there are significant risks and challenges associated with their development and deployment[72] - Cybersecurity risks continue to evolve, with increasing sophistication in attacks that could compromise system integrity[135] - The company relies on third-party cloud infrastructure, which poses risks of data breaches and service interruptions[134] - The company’s reliance on a single cloud services provider may hinder operational scalability and increase vulnerability to service disruptions[139] - The regulatory landscape for artificial intelligence and machine learning is rapidly changing, which may adversely affect the company's operations and financial condition[155] Shareholder and Capital Issues - The company reported that as of December 31, 2025, it had 169,049,616 ordinary shares outstanding, with 8,008,635 shares subject to outstanding awards under share incentive plans[220] - The board of directors authorized a repurchase program of up to $200 million for ordinary shares, with no minimum purchase requirement[212] - Approximately 38% of the company's ordinary shares are beneficially owned by executive officers, directors, and significant shareholders, which may limit other shareholders' influence on corporate matters[214] - The company may face increased refunds and chargebacks due to uncertain economic conditions, which could adversely impact its results of operations[205] - The company may face difficulties in raising additional capital, which could limit its ability to invest in new technologies and expand operations[187] Employee and Cultural Considerations - High-quality support is critical for retaining and attracting merchants, with increased costs expected as the business expands[145] - The company emphasizes the importance of maintaining its corporate culture to support innovation, creativity, and teamwork as it grows geographically[189] - Attracting and retaining skilled employees is critical, with competition for talent being intense, particularly in software engineering[179] - Economic downturns may necessitate cost-saving initiatives, potentially impacting employee morale and productivity[207] - The company faces risks from activist shareholders that could disrupt operations and divert management's attention[208]

Revenue Growth - Total revenue for Q4 2025 reached $6.2 billion, a 439.9% increase year-over-year, driven by higher digital asset trading activity and client growth [5]. - Full year 2025 total revenue was $16.2 billion, reflecting a 424.3% year-over-year increase, primarily from digital asset sales and subscription services [5]. - Digital asset sales revenue for Q4 2025 was $6.0 billion, a 531.3% increase from $955.5 million in Q4 2024 [9]. - Subscriptions and services revenue for Q4 2025 was $39.3 million, a 75.2% increase year-over-year [6]. - Total revenue for the year ended December 31, 2025, reached $16,152,121, a significant increase from $3,080,967 in 2024, representing a growth of approximately 424% [23]. Client and User Growth - The number of clients grew by 103.5% year-over-year to 5,322, while the number of users increased by 14.0% to 1.2 million [9]. Financial Performance - Net loss for Q4 2025 was $(50.0) million, compared to net income of $129.4 million in Q4 2024, largely due to declines in digital asset prices [5]. - Adjusted EBITDA for Q4 2025 was $12.1 million, up 188.0% year-over-year, indicating strong operating leverage [5]. - Net income for the year ended December 31, 2025, was a loss of $14,782 thousand compared to a profit of $156,554 thousand in 2024 [26]. - Adjusted EBITDA for the year ended December 31, 2025, was $32,411 thousand, significantly higher than $3,227 thousand in 2024 [28]. Asset and Liability Changes - Total current assets increased dramatically to $4,527,202 as of December 31, 2025, from $672,674 in 2024, reflecting a growth of approximately 572% [20]. - Total liabilities rose to $4,230,119 as of December 31, 2025, compared to $354,406 in 2024, marking an increase of about 1,192% [20]. - The company’s cash and cash equivalents increased to $106,275 in 2025 from $87,424 in 2024, a growth of approximately 21% [20]. - The total stockholders' equity decreased to $318,548 in 2025 from $328,871 in 2024, a decline of about 3% [21]. Expenses and Impairments - The company incurred interest expenses of $10,848 for the year ended December 31, 2025, compared to $1,630 in 2024, indicating a significant increase of approximately 566% [23]. - The company incurred stock-based compensation expenses of $3,389 thousand in 2025, compared to $2,676 thousand in 2024 [26]. - The company reported a goodwill impairment charge of $36,496 in 2024, which was not present in 2025, indicating a recovery from this specific financial burden [23]. Cash Flow and Investments - Net cash provided by operating activities increased to $29,971 thousand in 2025 from $10,683 thousand in 2024 [26]. - Cash flow used in investing activities was $114,325 thousand in 2025, compared to $58,917 thousand in 2024 [27]. - Proceeds from borrowings to support loans amounted to $158,665 thousand in 2025, up from $30,000 thousand in 2024 [27]. Market Adjustments - Digital asset fair market value adjustment resulted in a gain of $34,660 thousand in 2025, contrasting with a loss of $116,322 thousand in 2024 [26]. - The company experienced a net change in unrealized appreciation on digital assets of $38,708 thousand in 2025, compared to a loss of $112,001 thousand in 2024 [28]. Business Expansion - The company launched its derivatives business in Q1 2026, achieving approximately $3 billion in notional trading volume and over $3 million in revenue [2]. - BitGo secured approval from the Office of the Comptroller of the Currency in December 2025, becoming the first public federally chartered digital asset infrastructure provider [9]. - The company expanded its geographic presence, including broadening its license in Germany and securing custody broker-dealer status in Dubai [9].

Technology and Product Development - The company has developed scalable Wireless Power Network (WPN) technology that enables RF-based charging for battery-free IoT devices, enhancing supply chain capabilities from limited tracking to overall business intelligence [13]. - The patent portfolio exceeds 300 patents, supporting both near-field and at-a-distance wireless power transmission across multiple device categories, including retail sensors and asset trackers [14]. - The first WPN-enabled product was launched in 2019, with significant product releases including the PowerBridge transmitter systems in Q4 2021 and the battery-free e-Sense tag in Q2 2025 [15]. - The business strategy focuses on the commercialization of RF-based wireless power solutions for low-power IoT applications, emphasizing interoperability and multi-vendor compatibility [17]. - The WPN platform supports one-to-many power delivery, allowing a single transmitter to power multiple devices, enhancing operational efficiency in commercial environments [24]. - The primary transmitter offering, PowerBridge, is designed for at-a-distance wireless power delivery in retail, logistics, and healthcare settings [35]. - The company has developed commercial products and working prototypes utilizing its technology, but additional features and performance specifications are still under development [73]. - The company anticipates further releases of wireless power-enabled products as it continues to innovate its technology applications [172]. Financial Performance - Revenue for 2025 reached $5.6 million, a 633% increase from $0.8 million in 2024, primarily driven by commercial applications with multinational retailers, including two Fortune 10 companies [187]. - Cost of revenue for 2025 was $3.6 million, up 376% from $0.8 million in 2024, attributed to higher sales volume of PowerBridge Pro transmitters [188]. - Gross profit for 2025 was approximately $2.0 million, a significant increase from a gross profit of $12,000 in 2024, reflecting improved product margins [188]. - Operating expenses totaled $12.0 million in 2025, down 35% from $18.4 million in 2024, contributing to a loss from operations of $10.0 million [189]. - The net loss for 2025 was $9.6 million, down from $18.4 million in 2024 [198]. - The company had an accumulated deficit of approximately $410.0 million as of December 31, 2025, indicating a limited history of generating meaningful product revenue [64]. - Cash on hand as of December 31, 2025, was $10.4 million, with an increase to $39.4 million by March 23, 2026 [210][211]. - The company has sufficient cash to fund operations for the next 12 months based on current levels and cost reduction efforts [211]. Market and Economic Conditions - Current global economic conditions, including inflation and geopolitical tensions, pose significant risks to the company's operations and financial position [22]. - The ongoing global economic uncertainty, including inflation and geopolitical tensions, poses risks to the company's operations and financial position [173]. - Inflation has adversely affected the company's liquidity and overall cost structure, with expectations of continued cost increases in supply chain and labor [72]. - Adverse macroeconomic conditions, including rising interest rates and geopolitical instability, could negatively impact the company’s business and operating results [149]. Risks and Challenges - The company faces risks related to technology development, including the potential inability to demonstrate commercial feasibility or achieve profitability [57]. - The company is subject to various risks, including reliance on a few major customers, which may adversely affect revenue and operating results [62]. - Competition from established and emerging companies may hinder the company's ability to maintain its competitive position and achieve market acceptance [88]. - The company faces risks related to market acceptance of its RF-based charging systems, which are crucial for generating necessary revenue [78]. - The company relies on third-party components from limited or sole source suppliers, which could disrupt manufacturing and sales if these components become unavailable [96]. - The company may require additional financing to achieve its long-term business plans, with no guarantee that such financing will be available on acceptable terms [67]. - The company may face write-downs for excess or obsolete inventory if demand forecasting and inventory management are not effectively executed [106]. - Changes in U.S. and international trade policies, including tariffs on imports, could adversely affect material costs and demand for the company's products [100]. Intellectual Property and Regulatory Compliance - The company maintains a robust intellectual property portfolio, with over 300 issued patents related to wireless power technology, ensuring a competitive advantage [42]. - The company has received regulatory approvals from the FCC for its products, ensuring compliance with safety requirements for RF-based wireless power transmission [45]. - Regulatory approvals for technology involving RF energy are costly and time-consuming, and failure to obtain them could materially impact business operations [126]. - The company faces potential product liability claims, recalls, and warranty claims that could significantly increase legal costs and harm business operations [116]. - Patent infringement lawsuits could lead to significant legal costs and operational disruptions, impacting the company's ability to sell products [114]. Employee and Operational Aspects - The company has 27 full-time employees, with 12 being engineers, and maintains a good relationship with its employees [51]. - The company relies on outsourced manufacturing processes and is engaged with contract manufacturing partners both domestically and internationally [50]. - The company’s success depends on its ability to attract and retain qualified personnel and secure sufficient capital for ongoing research and development [95]. - Retaining key executives is crucial for implementing business plans, and losing them could delay strategic initiatives [127]. Future Outlook - The company does not anticipate paying cash dividends in the foreseeable future, focusing instead on reinvesting earnings into the business [167]. - The stock price is likely to remain volatile due to various external factors, including regulatory announcements and macroeconomic conditions [136]. - The company is transitioning from R&D to commercial production, with uncertainty regarding the sufficiency of resources and revenue to sustain operations [212].